Cargando…
Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type‐1 insulin‐like growth factor receptors in neuronal cells
Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with synaptic dysfunction, pathological accumulation of β‐amyloid (Aβ), and neuronal loss. The self‐association of Aβ monomers into soluble oligomers seems to be crucial for the development of neurotoxicity (J. Neur...
Autores principales: | Zimbone, Stefania, Monaco, Irene, Gianì, Fiorenza, Pandini, Giuseppe, Copani, Agata G., Giuffrida, Maria Laura, Rizzarelli, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770784/ https://www.ncbi.nlm.nih.gov/pubmed/29094448 http://dx.doi.org/10.1111/acel.12684 |
Ejemplares similares
-
β-amyloid monomers drive up neuronal aerobic glycolysis in response to energy stressors
por: Santangelo, Rosa, et al.
Publicado: (2021) -
A promising connection between BDNF and Alzheimer’s disease
por: Giuffrida, Maria Laura, et al.
Publicado: (2018) -
Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention
por: Gopalakrishna, Rayudu, et al.
Publicado: (2023) -
CYCLIC ADENOSINE MONOPHOSPHATE IN PHAGOCYTIZING GRANULOCYTES AND ALVEOLAR MACROPHAGES
por: Seyberth, H. W., et al.
Publicado: (1973) -
Downregulation of cyclic adenosine monophosphate levels in leukocytes of hibernating captive black bears is similar to reported cyclic adenosine monophosphate findings in major depressive disorder
por: Tsiouris, John A., et al.
Publicado: (2023)